In December 2024, Elicio announced the completion of enrollment of the randomized Phase 2 AMPLIFY-7P clinical trial ( ...
ProMIS expects to report six-month interim results from PRECISE-AD in the first half of 2026, with topline results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback